Best Shoes for Midfoot Arthritis
Compare footwear fit and device room for midfoot arthritis. Understand the limits of stiffness measurements, orthotic studies and untested shoe recommendations.
On this page
- Quick answer: what to look for
- Where midfoot arthritis is, and why bending is the problem
- What the research actually supports — and where it stops
- Sole stiffness is the property, and only twenty-four shoes here have both figures
- The shoes whose published figures fit the brief
- The lace problem, and the thirty-second fix
- Where to buy
- Questions people ask
- What happens next on this page
- Related conditions
Spec analysis — not yet tested · Published September 2026
Nothing on this page has been measured by us. Every shoe figure below is either the brand’s own published specification or a laboratory measurement published by RunRepeat, and the source is printed beside each one. No shoe here carries a score or the Podiatrist Tested seal. How we test →
Clarification (8 October 2026): Corrected the trial’s follow-up intervals and control-group result. The study excluded established midfoot osteoarthritis and did not test the listed retail shoes; construction measurements are not a treatment ranking.
Midfoot osteoarthritis is wear in the joints across the middle of the foot — the tarsometatarsal and naviculocuneiform joints, in the arch between the ankle and the ball. It is common after fifty, it is commonly missed, and it is one of the very few foot conditions where the treatment clinicians reach for most often is footwear. That is not a marketing claim: in a survey of 103 practising podiatrists, footwear advice was the single most-used management strategy at 97%, ahead of orthoses, taping, education and exercise. This page is about what that advice should actually consist of, and what the evidence behind it is worth.
Where to start
Three places to start, drawn from the comparison further down this page. None has been measured on our own bench, so none is scored.
- Walking-shoe construction: Brooks Addiction Walker 2No torsional-rigidity value is reported here; construction does not establish an arthritis-treatment result.Check price — paid link
- The most heel hold: Brooks Ghost 18The stiffest heel counter on file, in four widths, with a removable insole.Check price — paid link
- Cushioning construction: Brooks Glycerin 23The reported foam-hardness sample is a construction comparison, not a rule for choosing a shoe by symptoms.Check price — paid link
Paid links: we earn a commission at no extra cost to you, and it never changes what is listed. Construction comparisons and their evidence limits are explained further down this page.
Where midfoot arthritis is, and why bending is the problem
The midfoot is the run of small joints between the back of the foot and the long bones of the toes — principally the tarsometatarsal joints, where the metatarsals meet the cuneiforms and the cuboid, and the naviculocuneiform joints just behind them. In a healthy foot these move very little. They are built to lock into a rigid lever at push-off, and the ligaments that hold them are short and strong.
When those joints become arthritic, the pain is at its worst in the part of the step where they are being asked to bend and then stiffen: mid-stance into toe-off. That is why the story people tell is so consistent — fine sitting down, sore after a long walk, and worst on the push. It is also why the mechanical answer is unusually simple to state. If the joint hurts when it bends, stop it bending.
A cross-sectional study compared 61 people with symptomatic radiographic midfoot osteoarthritis with 61 age- and sex-matched controls and reported differences in arch posture and walking mechanics. An association does not establish the reason for those differences or show that a particular shoe will prevent arch change or treat pain.
| What you notice | More consistent with | Where to read next |
|---|---|---|
| Aching across the top and middle of the arch, worse after walking and worst at push-off | Midfoot osteoarthritis | This page |
| A bony ridge on top of the midfoot that hurts where the laces cross it | A dorsal osteophyte, which is arthritis showing itself from outside | This page — see the lacing section below |
| Pain in a cord on top of the foot that you can trace with a finger, worse the day after a long walk or a tightly laced shoe | Extensor tendonitis | Shoes for extensor tendonitis |
| Sharp pain under the heel on the first steps of the morning | Plantar fasciopathy | Shoes for plantar fasciitis |
| Pain on the outer edge of the midfoot, often after a sprain | Cuboid syndrome | Shoes for cuboid syndrome |
| A stiff, flat foot since the teenage years, with repeated ankle sprains | Tarsal coalition | Shoes for tarsal coalition |
| Midfoot pain and swelling after a twisting injury, painful to weight-bear | A Lisfranc injury — and a reason to be seen quickly | Shoes after a Lisfranc injury |
An orientation table, not a diagnosis. Midfoot osteoarthritis is confirmed on imaging, and an acute midfoot injury is a different problem with a different urgency. See our editorial policy.
What the research actually supports — and where it stops
The sources below examine orthoses, stiffening inserts and mechanical midfoot pain. They do not directly test the listed retail shoes as treatments for established midfoot osteoarthritis.
- The whole evidence base is six trials and 231 people. Searching from inception to February 2023, the reviewers found one feasibility trial and five case series. Every one of the six was judged to be of poor methodological quality. That is the size of the foundation under everything anyone tells you about this condition.
- Shoe stiffening inserts produced the largest reported effects on pain. Two trials, medium-to-huge effects in the short term, with small effects on function. A shoe stiffening insert is a rigid plate placed inside the shoe to stop the sole — and the midfoot on top of it — from bending.
- Arch contouring foot orthoses were next. Two trials, effects on pain ranging from none to large in the short and medium term, and small-to-very-large effects on function.
- Image-guided corticosteroid injections helped and then faded. Favourable in the short term, small effects in the medium term, minimal in the long term.
- And the authors’ own verdict: these interventions may be effective, and rigorous randomised trials are required to find out. Two trials reported minor adverse events. None of the six reported a quality-of-life outcome at all.
Lim PQX, Lithgow MJ, Kaminski MR, Landorf KB, Menz HB, Munteanu SE. Efficacy of non-surgical interventions for midfoot osteoarthritis: a systematic review. Rheumatology International 2023;43(8):1409–1422. Open access.
A later exploratory trial studied mechanical midfoot pain with MRI-confirmed bone marrow lesions. It compared fitted pre-formed orthoses with cushioning insoles and excluded established clinical/radiographic midfoot osteoarthritis. It is adjacent evidence, not direct proof that a listed shoe treats arthritis.
| Outcome and reporting interval | Pre-formed orthoses (n=27) | Cushioning insoles (n=15) |
|---|---|---|
| Pain, baseline to week 6 (100 mm visual analogue scale) | −14.8 mm (CI −22.3 to −7.3) | −7.4 mm (CI −19.9 to 5.2) |
| Pain, baseline to week 12 (same scale; Table 2 completers) | −18.5 mm (CI −28.5 to −8.5) | −7.8 mm (CI −21.2 to 5.6) |
| Bone marrow lesion volume at 12 weeks | −1,544.4 mm³ (CI −3,660.4 to 571.6) | −315.8 mm³ (CI −1,528.2 to 896.7) |
Halstead and colleagues, full study and Table 2. Both groups’ average pain was lower than baseline at week 12. The table above uses the baseline-to-week-12 completer values; the paper’s abstract and interim interval reporting differ. The bone-lesion confidence intervals cross zero. This small exploratory study does not establish a preferred retail shoe or a cushioning-based arthritis rule.
The intervention studies concern devices rather than the named retail shoes. Their limitations prevent a proven best-shoe ranking. Whether a device fits and feels comfortable must be checked in the actual shoe; a specification or stiffness figure alone does not establish treatment benefit.
Sole stiffness is the property, and only twenty-four shoes here have both figures
Torsional rigidity describes resistance to twisting; forefoot flexibility describes resistance to bending under the outside laboratory’s method. These measurements describe the recorded shoe sample. They do not demonstrate that a retail sole replicates a prescribed stiffening insert or establish a treatment threshold for midfoot arthritis.
| Shoe | Torsional rigidity | Bending stiffness | Who published it |
|---|---|---|---|
| Brooks Glycerin 23 | 14.0 Nm | Longitudinal 15.2 N (lab average 15.5) | RunRepeat lab |
| Brooks Ghost 18 | 12.2 Nm | Forefoot 12.3 N to bend | RunRepeat lab |
| Brooks Adrenaline GTS 25 | 14.3 Nm | Longitudinal 14.3 N | RunRepeat lab |
| The other 21 shoes the lab has twisted | 10.3 to 20.5 Nm; median of all 24, 14.5 | Forefoot 10.9 to 23.1 N | RunRepeat lab |
| Every other shoe on this site | No figure | Forefoot 10.1 to 27.4 N on 11; no figure on the rest | RunRepeat lab, for the 11 |
Read September 2026; the Glycerin 23 and Ghost 18 figures are also cited on each shoe’s own page here. No brand publishes either measurement for any shoe. Twenty-four torsional readings are a scale, and the three Brooks shoes named here sit 13th, 14th and 19th on it, all below the median of 14.5 Nm. Every figure on this site and its publisher is in the shoe spec database.
What the fuller data shows is a wide spread on both measurements. Of the 24 shoes we review that the lab has twisted, the stiffest are the ASICS Gel-Nimbus 28 at 20.5 Nm, the ASICS Gel-Kayano 32 at 20.2 and the HOKA Arahi 8 at 19.5, and the least resistant is the New Balance 1080v15 at 10.3; the chart of all 24 shows every one. To bend at the forefoot, the 35 shoes the lab has measured run from 10.1 N (Brooks Adrenaline GTS 24) to 27.4 N (HOKA Bondi SR), with a median of 15.3. The three Brooks shoes in the table sit below the median on both.
The chart covers a limited set of measured models and cannot establish which unmeasured therapeutic or rocker designs will suit an individual. Rocker geometry and bending resistance are different properties; the cited studies do not validate a universally preferred retail geometry or shoe.
Which leads to the practical conclusion this page is built on, and it is not the conclusion a shoe site would prefer: the stiffness you can actually control is the stiffness you put inside the shoe. A shoe stiffening insert or a carbon plate has a stated thickness and a stated rigidity; a shoe does not. Our page on carbon fibre insoles covers what those plates are and how they differ, and the orthotic volume rating is a one-minute shop test for whether a shoe will take one once its own insole is out.
The shoes whose published figures fit the brief
Three untested shoe designs to compare for fit and device accommodation. No score or proven arthritis-treatment ranking is assigned; published construction figures are not clinical outcomes.
Both stiffness numbers, and the top heel-counter grade
Brooks Ghost 18 Spec analysis
It is one of the 24 shoes on the site for which a laboratory has measured both properties: torsional rigidity 12.2 Nm and forefoot flexibility 12.3 N to bend. Its heel counter graded 5 out of 5, the top grade, which six other shoes the lab has measured share, and its insole is 5.0 mm and removable, which is a useful amount of room to give back when a plate or an orthosis goes in. Narrow through X-Wide.
The honest caveat: on the number this page turns on, it is one of the more flexible shoes the lab has twisted — 12.2 Nm, 19th of the 24 shoes we review, against the Glycerin’s 14.0 and a median of 14.5. And Brooks publishes no stack height at all for it, on any regional site, so the only brand geometry you get is a stated 10 mm drop; RunRepeat’s lab measured it at 12.2 mm, from 37.3 mm at the heel to 25.1 mm at the forefoot.
| Published figure | Value |
|---|---|
| Torsional rigidity | 12.2 Nm RunRepeat lab |
| Forefoot flexibility | 12.3 N to bend RunRepeat lab |
| Heel-counter stiffness | 5 / 5 RunRepeat lab |
| Insole | 5.0 mm, removable RunRepeat lab · Brooks |
| Heel-to-toe drop | 10 mm Brooks |
| Stack heights | Not published by Brooks on any locale — |
| Widths | Narrow, Normal, Wide, X-Wide Brooks |
| List price | $150 Brooks |
Soft underfoot, mid-table in torsion
Brooks Glycerin 23 Spec analysis
The laboratory values above describe the measured sample’s construction. They do not establish that the Brooks Glycerin 23 is clinically preferable for midfoot arthritis or that combining a soft surface with a particular twist rating treats pain.
The honest caveat: the width range is the narrowest of the three, men’s D and 2E only, and the 4.4 mm insole gives back the least room of the three when you pull it out for a plate. At $175 it is also the most expensive shoe here.
| Laboratory figure | Value |
|---|---|
| Torsional rigidity | 14.0 Nm RunRepeat lab |
| Longitudinal stiffness | 15.2 N (lab average 15.5) RunRepeat lab |
| Midsole softness | 29.2 AC (lab average 35.6) RunRepeat lab |
| Insole | 4.4 mm, removable RunRepeat lab |
| Heel stack · forefoot stack | 37.2 mm · 29.0 mm RunRepeat lab |
| Widths | M: D/2E Brooks |
| List price | $175 Brooks |
Walking-shoe specification comparison
Brooks Addiction Walker 2 Spec analysis
The Brooks Addiction Walker 2 is described as a motion-control walker. Its reported 48.7 Asker C hardness and the On Cloudmonster 3 comparison describe measured samples; they do not establish treatment of the arch changes seen in midfoot arthritis. Check the actual width, comfort and room for any prescribed device.
Fit limitation: the evidence here does not establish a diagnosis-based reason to recommend or exclude the Addiction Walker 2. It has no reported torsional figure in this table, and its listed 411 g weight is a construction specification. The tarsal coalition guide addresses a different condition; neither page’s label substitutes for an assessment or actual fit check.
| Laboratory figure | Value |
|---|---|
| Midsole softness | 48.7 AC (lab average 35.6) RunRepeat lab |
| Torsional rigidity | No sourced figure in this comparison — |
| Heel-counter stiffness | 3 / 5 RunRepeat lab |
| Heel stack · forefoot stack | 35.7 mm · 23.5 mm RunRepeat lab |
| Weight | 411 g Brooks |
| Widths | M: B/D/2E/4E · W: 2A/B/D/2E Brooks |
| List price | $140 Brooks |
The lace problem, and the thirty-second fix
Midfoot arthritis often announces itself from the outside as a hard ridge on top of the arch — a dorsal osteophyte, bone the joint has laid down at its margins. It sits directly under the lacing, and it is the reason a great many people with this condition report that no shoe is comfortable and cannot say which part is wrong. The shoe is not too tight overall. It is tight in one place, and that place is about a centimetre across.
The fix costs nothing and takes half a minute: lace around the bump rather than over it. Instead of crossing at every eyelet, run the lace straight up the side on both sides for the pair of eyelets that sit over the prominence, and resume crossing above it. That leaves a window with no pressure over the sore spot while the rest of the shoe still holds. It is the same principle as the quarter-trim-line modification our Haglund’s page describes for the back of the heel: move the hardware off the bone rather than padding the bone.
Two things follow for buying. A shoe with more eyelet pairs gives you more places to put the window, and one with a padded, gusseted tongue spreads what pressure is left. And a shoe you cannot re-lace at all — a slip-on, a knitted one-piece upper, an elastic-laced hands-free design — takes this option away entirely. That is a real reason to prefer a conventional lace-up here even though slip-ons are easier to get on, and it is the reverse of the advice we give on pages about arthritis in the hands or hips.
And there is now a measurement behind the half of this that is usually hand-waved. The reason a shoe can feel acceptable in the shop and intolerable twenty minutes later is not that it got tighter — it is that the pressure over the instep does not hold still. In March 2026, twenty trained marathoners each ran two 50-minute treadmill sessions, once in conventional laces and once in a wrapping closure — a dial-based lacing system — with dorsal foot pressure recorded throughout. Pressure fluctuation across the top of the foot was significantly smaller with the dial, as was peak tibialis anterior activation (p < 0.036 at several checkpoints), and the runners reported less discomfort in the mid-to-late stages of the run (p < 0.025). If your problem is one hard ridge a centimetre across sitting under the laces, variability is the thing that hurts you, and it is now a measured quantity rather than a hunch.
Read carefully before buying a dial shoe on the strength of that. The study compared a dial system with ordinary laces in healthy runners with no midfoot arthritis at all, on a treadmill, and it measured comfort, pressure and muscle activity — not pain, and not anything about an arthritic joint. It also tested a closure system, not a lacing pattern, so it is not evidence for the window-lacing fix described above; that remains sound reasoning that costs nothing to try. ⚠️ And the number most likely to be repeated from it is the one that failed: laces came undone in 10 per cent of the conventional trials and none of the dial trials, but p = 0.500 — two events against zero, in twenty runs. That is not a finding.
What we would actually take from it: try the free fix first (thirty seconds, no purchase), and if a dial-closure shoe is already in front of you, there is now one published reason to think it holds the dorsum more evenly than laces do. That is a long way from a recommendation.
Flexible and zero-drop designs: evidence limits
The Altra Torin 9 and Paradigm 8 are specification comparisons, not tested exclusions for midfoot arthritis. Zero drop describes heel-to-toe geometry rather than proving flexibility or clinical suitability. The evidence here does not establish that all zero-drop or flexible designs are unsuitable. See the zero-drop shoes guide for the separate geometry context.
A manual twist or bend check may describe construction, but it cannot measure how an arthritic joint moves in use or establish symptom relief. No retail-shoe flexibility cutoff has been validated by the evidence cited here.
Where to buy
Disclosure: the links below are paid links. If you buy through them Amazon pays us a commission at no cost to you. Commissions never influence a score, a ranking or the seal, and nothing on this page is scored because none of these shoes has been tested by us — see our independence policy.
The three shoes named in the comparison above. Prices and availability change, so check the listing. None has been measured on our own bench, so none is scored.
Questions people ask
Is a carbon plate the same as a shoe stiffening insert?
Close enough to matter, and different enough to ask about. Both are rigid full-length or three-quarter-length plates that sit under the foot and stop the sole bending. Carbon fibre is one material; the trials in the systematic review used what they called shoe stiffening inserts, which in practice have been carbon fibre and moulded polymer plates of varying rigidity. What has never been established is how stiff a plate needs to be, or where along the foot it should end — the review’s own conclusion is that rigorous trials are still required. Our carbon fibre insoles page covers what is actually sold.
Do I want a rocker sole or a stiff sole?
A rocker describes sole shape; stiffness describes resistance to bending. The review does not establish a required retail rocker geometry or a universally best combination for midfoot arthritis. Compare the actual shoe and any prescribed insert rather than treating these design labels as proven treatment outcomes.
Will a softer, more cushioned shoe help?
The trial does not establish whether a softer retail shoe will help a person with midfoot arthritis. Both study groups improved from baseline, and established clinical/radiographic midfoot OA was excluded. The shoes listed here were not the tested interventions.
What will a podiatrist actually do?
The cited survey asked 103 practising Australian podiatrists about their practice. They reported footwear advice 97 percent, orthotic therapy 85 percent, strapping/taping 81 percent, education 79 percent and exercise therapy 75 percent; these are practice frequencies, not proof of treatment effectiveness. A third expected satisfactory response within two months, and 36 percent described referral for co-management between two and three months. Those expectations do not establish a universal reassessment timetable; the appropriate next step depends on the assessed problem and response.
Why does it hurt more on stairs and hills?
The cited pressure study describes associations during walking. It did not test pain on stairs or hills, establish how often patients stop these activities, or show that a named stiff-soled shoe improves those symptoms. Pain with a particular activity needs individual assessment rather than a retail-shoe rule.
Is this the same as a bunion or big-toe arthritis?
Midfoot osteoarthritis and big-toe joint arthritis affect different locations. The cited evidence does not establish that the same rigid sole will help both or a universal plate length or placement. Our arthritis in the feet guide gives related context; assessment is needed to identify the joint and suitable device.
What happens next on this page
No original shoe measurements, wear observations or clinician-review records are available for this page. Future mechanical measurements could describe construction, but would not alone establish clinical effectiveness. Until documented testing exists, retain source labels and identify fit conclusions as limited specification analysis.
- Lim PQX, Lithgow MJ, Kaminski MR, Landorf KB, Menz HB, Munteanu SE. Efficacy of non-surgical interventions for midfoot osteoarthritis: a systematic review. Rheumatology International 2023;43(8):1409–1422. doi:10.1007/s00296-023-05324-3 (PMID 37093273). Open access. Source of the six trials and 231 participants, the poor-quality rating of all six, the medium-to-huge short-term pain effects for shoe stiffening inserts, the no-to-large effects for arch contouring orthoses, the corticosteroid-injection findings, the absence of any quality-of-life outcome, and the call for rigorous randomised trials.
- Halstead J, Keenan AM, Conaghan PG, McGonagle D, Redmond AC. Effect of Foot Orthoses on Midfoot Pain and the Volume of Bone Marrow Lesions in the Midfoot: A Randomized Mechanism of Action Study. Arthritis Care & Research 2026;78(4):547–556. doi:10.1002/acr.25648 (PMID 40948063). Open access. Source of every figure in the 12-week table — 42 participants randomised 2:1, 108 bones with lesions at a mean of 2.5 per person, and the visual-analogue and lesion-volume results with their confidence intervals.
- Lim PQX, Menz HB, Landorf KB, Kaminski MR, Paterson KL, Munteanu SE. Assessment and management of midfoot osteoarthritis by podiatrists in Australia: a cross-sectional survey of current practice. Rheumatology International 2025;45(6):141. doi:10.1007/s00296-025-05881-9 (PMID 40353885). Open access. Source of the 103 respondents, the statement that the condition lacks clinical guidelines, the 97% footwear advice figure and the rest of the treatment and assessment percentages, and the two-to-three-month referral timing.
- Lithgow MJ, Buldt AK, Munteanu SE, Marshall M, Thomas MJ, Peat G, Roddy E, Menz HB. Plantar pressures in people with midfoot osteoarthritis: cross-sectional findings from the Clinical Assessment Study of the Foot. Gait & Posture 2024;108:243–249. doi:10.1016/j.gaitpost.2023.12.008 (PMID 38141537). Source of the 61 matched case-control comparison and the finding of a lowered medial longitudinal arch, greater lateral push-off and less propulsion at toe-off.
- RunRepeat laboratory measurements of torsional rigidity, forefoot flexibility, longitudinal stiffness, heel-counter stiffness, insole thickness, stack heights and midsole softness for the three shoes picked above; read September 2026. Each figure is also cited on that shoe’s own page here. The other figures, ranges and ranks this page quotes — torsional rigidity for 24 shoes, bending stiffness for 35, midsole softness for 33 — are RunRepeat laboratory figures too, read 28 September 2026.
- Brand-published specifications from Brooks — stated drop, widths, insole removability, weight and list price; read September 2026.
- Podiatrist Tested shoe spec database — the 43-shoe dataset behind every count on this page, with the publisher of each individual figure.
- Wang Y, Huang W, Zhang N, Chen TL, Zhang M. Effects of a wrapping closure lacing system on wearing comfort, lock-in stability, and lower-limb muscle demand during prolonged running. Frontiers in Sports and Active Living 2026;8:1775046. doi:10.3389/fspor.2026.1775046 (PMID 41918570), open access. Source of the dial-versus-laces dorsal pressure and comfort findings. ⚠️ Twenty healthy trained marathoners on a treadmill, no midfoot arthritis; outcomes are comfort, pressure and EMG rather than pain; the lace-loosening difference did not reach significance (p = 0.500).
No shoe on this page has been tested by us. Nothing here is a diagnosis or a treatment recommendation, and midfoot osteoarthritis is confirmed on imaging; see our editorial policy.
- Best shoes for arthritis in the feet — the whole set of joints, and the page to start from if you are not sure which one is yours.
- Carbon fibre insoles — the intervention with the largest reported effect for this condition, and what is actually sold.
- Orthotic volume rating — the one-minute shop test for whether a shoe will take a plate once its own insole is out.
- Best shoes after a Lisfranc injury — the acute injury in the same joints, and a common route into this diagnosis.
- Best shoes for cuboid syndrome — lateral midfoot pain that is mobile rather than arthritic.
- Best shoes for tarsal coalition — where we rule out the same shoe we recommend here, and why.
- Best shoes for flat feet — the arch lowering this condition is associated with.
- Shoe spec database — every published figure on this site in one table, with who published each one.
- Best shoes for Freiberg’s disease — the same argument for a stiff sole, one joint further forward.
Related conditions
- Best shoes for sinus tarsi syndrome — pain just in front of the outer ankle
- Best shoes for psoriatic arthritis — when the arthritis is inflammatory, not wear-and-tear
- Best shoes for peroneal tendonitis — the tendons along the outer foot
Recently reviewed
Individual shoe pages state their evidence tier, published measurements and who should skip them.
Saucony Endorphin Speed 5
Spec AnalysisLight plated neutral trainer. Saucony publishes both stack heights and they match its 8 mm drop — not yet tested.
HOKA Mach 6
Spec AnalysisLower, firmer neutral HOKA. HOKA publishes a 5 mm drop and neither stack height — not yet tested.
ASICS Novablast 5
Spec AnalysisBouncy high-stack neutral. ASICS publishes an 8 mm drop and neither stack height — not yet tested.
Our funding and evidence policy
We earn affiliate commissions from qualifying purchases. Our policy is to assess published evidence and fit needs rather than rank products by commission rate. Current reviews are specification analyses; see our method for their limits.